China’s Health Silk Road: High-Visibility Soft Power, Limited Substitute for Western Global Health Funding
The source assesses China’s Health Silk Road as a branding-driven, decentralized health engagement model that surged during COVID-19 but declined by 2023, limiting its ability to replace Western grant-funded programs. It suggests China will likely pursue narrow, high-impact leadership areas—especially vaccines and related technologies—rather than sustained, broad-spectrum global health financing.